Edesa Biotech Overview

  • Founded

  • 2015

Founded
  • Status

  • Public

  • Employees

  • 16

Employees
  • Stock Symbol

  • EDSA

Stock Symbol
  • Investments

  • 1

  • Share Price

  • $0.91

  • (As of Friday Closing)

Edesa Biotech General Information

Description

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Contact Information

Website
www.edesabiotech.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 100 Spy Court
  • Markham, Ontario L3R 5H6
  • Canada
+1 (289) 000-0000

Edesa Biotech Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edesa Biotech Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.91 $0.90 $0.76 - $2.81 $18.7M 20.6M 79.7K -$0.62

Edesa Biotech Financials Summary

In Thousands,
USD 		TTM 31-Mar-2023 FY 2022 30-Sep-2022 FY 2021 30-Sep-2021 FY 2020 30-Sep-2020
EV 10,172 1,477 89,895 74,538
Revenue 0 0 0 329
EBITDA (13,345) (17,493) (13,235) (6,344)
Net Income (13,270) (17,549) (13,343) (6,364)
Total Assets 10,673 11,576 14,585 10,762
Total Debt 130 19 99 164
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Edesa Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edesa Biotech‘s full profile, request access.

Request a free trial

Edesa Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in expl
Drug Discovery
Markham, Canada
16 As of 2022
0000
000000000 0000

000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
000000000000000
Cranford, NJ
00 As of 0000
000.00
000000000 000.00

000 00

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000 000000000
Indianapolis, IN
00000 As of 0000
000000 - 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edesa Biotech Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Citius Pharma Formerly Angel backed Cranford, NJ 00 000.00 000000000 000.00
000 00000 Corporation Indianapolis, IN 00000 000000 - 000
00000 000000 00000 Corporate Backed or Acquired Boulder, CO 00 000.00 00000000 000.00
00000 Corporation Mumbai, India 00000 00000000
000000 000000 0000 Formerly VC-backed Gothenburg, Sweden 00 000.00 000000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Edesa Biotech Executive Team (5)

Name Title Board Seat Contact Info
Par Nijhawan MD Founder, Chief Executive Officer, Secretary & Board Director
Michael Brooks Ph.D President
Leo Bonifacio Ph.D Director, Business Development
Gary Koppenjan Vice President, Investor Relations and Communications
Kathi Niffenegger Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
To view Edesa Biotech’s complete executive team members history, request access »

Edesa Biotech Board Members (9)

Name Representing Role Since
Carlo Sistilli Edesa Biotech Board Member 000 0000
Frank Oakes Self Board Member 000 0000
Jennifer Chao Self Board Member 000 0000
Lorin Johnson Ph.D Self Board Member 000 0000
Par Nijhawan MD Edesa Biotech Founder, Chief Executive Officer, Secretary & Board Director 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Edesa Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edesa Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Edesa Biotech‘s full profile, request access.

Request a free trial

Edesa Biotech Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 07-Jun-2019 0000000000 00.000 Biotechnology 000 00000
To view Edesa Biotech’s complete acquisitions history, request access »